Literature DB >> 19443608

Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain.

Ravi Jasuja1, Jagadish Ulloor, Christopher M Yengo, Karen Choong, Andrei Y Istomin, Dennis R Livesay, Donald J Jacobs, Ronald S Swerdloff, Jaroslava Miksovská, Randy W Larsen, Shalender Bhasin.   

Abstract

Ligand-induced conformational perturbations in androgen receptor (AR) are important in coactivator recruitment and transactivation. However, molecular rearrangements in AR ligand-binding domain (AR-LBD) associated with agonist binding and their kinetic and thermodynamic parameters are poorly understood. We used steady-state second-derivative absorption and emission spectroscopy, pressure and temperature perturbations, and 4,4'-bis-anilinonaphthalene 8-sulfonate (bis-ANS) partitioning to determine the kinetics and thermodynamics of the conformational changes in AR-LBD after dihydrotestosterone (DHT) binding. In presence of DHT, the second-derivative absorption spectrum showed a red shift and a change in peak-to-peak distance. Emission intensity increased upon DHT binding, and center of spectral mass was blue shifted, denoting conformational changes resulting in more hydrophobic environment for tyrosines and tryptophans within a more compact DHT-bound receptor. In pressure perturbation calorimetry, DHT-induced energetic stabilization increased the Gibbs free energy of unfolding to 8.4 +/- 1.3 kcal/mol from 3.5 +/- 1.6 kcal/mol. Bis-ANS partitioning studies revealed that upon DHT binding, AR-LBD underwent biphasic rearrangement with a high activation energy (13.4 kcal/mol). An initial, molten globule-like burst phase (k approximately 30 sec(-1)) with greater solvent accessibility was followed by rearrangement (k approximately 0.01 sec(-1)), leading to a more compact conformation than apo-AR-LBD. Molecular simulations demonstrated unique sensitivity of tyrosine and tryptophan residues during pressure unfolding with rearrangement of residues in the coactivator recruitment surfaces distant from the ligand-binding pocket. In conclusion, DHT binding leads to energetic stabilization of AR-LBD domain and substantial rearrangement of residues distant from the ligand-binding pocket. DHT binding to AR-LBD involves biphasic receptor rearrangement including population of a molten globule-like intermediate state.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443608      PMCID: PMC2718745          DOI: 10.1210/me.2008-0304

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  63 in total

1.  Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.

Authors:  R K Tyagi; Y Lavrovsky; S C Ahn; C S Song; B Chatterjee; A K Roy
Journal:  Mol Endocrinol       Date:  2000-08

2.  Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.

Authors:  J S Sack; K F Kish; C Wang; R M Attar; S E Kiefer; Y An; G Y Wu; J E Scheffler; M E Salvati; S R Krystek; R Weinmann; H M Einspahr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

4.  Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.

Authors:  Bin He; Robert T Gampe; Andrew T Hnat; Jonathan L Faggart; John T Minges; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2005-12-19       Impact factor: 5.157

5.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

6.  Structural basis for antagonism and resistance of bicalutamide in prostate cancer.

Authors:  Casey E Bohl; Wenqing Gao; Duane D Miller; Charles E Bell; James T Dalton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

7.  Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.

Authors:  Hien T Le; Charlene M Schaldach; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

Review 8.  Molecular action of androgens.

Authors:  J Gobinet; N Poujol; Ch Sultan
Journal:  Mol Cell Endocrinol       Date:  2002-12-30       Impact factor: 4.102

9.  Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.

Authors:  Emily B Askew; Robert T Gampe; Thomas B Stanley; Jonathan L Faggart; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

10.  Protein stability induced by ligand binding correlates with changes in protein flexibility.

Authors:  María Soledad Celej; Guillermo G Montich; Gerardo D Fidelio
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

View more
  9 in total

1.  Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.

Authors:  Paul M Musille; Manish Pathak; Janelle L Lauer; William H Hudson; Patrick R Griffin; Eric A Ortlund
Journal:  Nat Struct Mol Biol       Date:  2012-04-15       Impact factor: 15.369

2.  Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society.

Authors:  R Thomas Zoeller; T R Brown; L L Doan; A C Gore; N E Skakkebaek; A M Soto; T J Woodruff; F S Vom Saal
Journal:  Endocrinology       Date:  2012-06-25       Impact factor: 4.736

Review 3.  Androgen receptor gene rearrangements: new perspectives on prostate cancer progression.

Authors:  Lucas J Brand; Scott M Dehm
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

4.  Pressure perturbation calorimetry of lipoproteins reveals an endothermic transition without detectable volume changes. Implications for adsorption of apolipoprotein to a phospholipid surface.

Authors:  Shobini Jayaraman; Ravi Jasuja; Mikhail N Zakharov; Olga Gursky
Journal:  Biochemistry       Date:  2011-04-20       Impact factor: 3.162

Review 5.  1-Carbon Cycle Metabolites Methylate Their Way to Fatty Liver.

Authors:  Amy Karol Walker
Journal:  Trends Endocrinol Metab       Date:  2016-10-24       Impact factor: 12.015

6.  Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor.

Authors:  Ettayapuram Ramaprasad Azhagiya Singam; Phum Tachachartvanich; Michele A La Merrill; Martyn T Smith; Kathleen A Durkin
Journal:  J Phys Chem B       Date:  2019-09-03       Impact factor: 2.991

7.  Allosteric conversation in the androgen receptor ligand-binding domain surfaces.

Authors:  Solène Grosdidier; Laia R Carbó; Víctor Buzón; Greg Brooke; Phuong Nguyen; John D Baxter; Charlotte Bevan; Paul Webb; Eva Estébanez-Perpiñá; Juan Fernández-Recio
Journal:  Mol Endocrinol       Date:  2012-05-31

Review 8.  Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus.

Authors:  Sugunadevi Sakkiah; Tony Wang; Wen Zou; Yuping Wang; Bohu Pan; Weida Tong; Huixiao Hong
Journal:  Int J Environ Res Public Health       Date:  2017-12-23       Impact factor: 3.390

9.  Cellular and Biophysical Pipeline for the Screening of Peroxisome Proliferator-Activated Receptor Beta/Delta Agonists: Avoiding False Positives.

Authors:  Natália Bernardi Videira; Fernanda Aparecida Heleno Batista; Artur Torres Cordeiro; Ana Carolina Migliorini Figueira
Journal:  PPAR Res       Date:  2018-04-12       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.